Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has The Targeted Therapy Market Growth Evolved From 2024 To 2025, And What’s Ahead?

In recent times, the targeted therapy market has seen robust growth. The market size is projected to increase from $103.84 billion in 2024 to $109.99 billion in 2025, with a compound annual growth rate (CAGR) of 5.9%. Factors that contributed to this growth during the historical period include developments in molecular biology, a rise in cancer cases, the popularity of personalized medicine, the approval of the FDA, and regulatory assistance.

The market for targeted therapy is set to experience significant expansion in the coming years. It is predicted to reach a worth of $146.89 billion in 2029, with a compound annual growth rate of 7.5%. The predicted growth during this period is driven by a range of factors including increasing oncology research, the rising need for precision medicine, the advent of immunotherapies, augmented investments in biopharmaceuticals, patient awareness, and advocacy. The forecast period will see trends such as the incorporation of artificial intelligence in drug discovery, patient advocacy and participation in treatment decisions, the growth of companion diagnostics, regulatory support for accelerated approvals, and an increase in investment in biotechnology and pharma.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9129&type=smp

How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theTargeted Therapy Market?

The surge in cancer incidence is predicted to boost the advancement of the targeted therapy market. The term cancer refers to disorders where abnormal cells can uncontrollably multiply and infect nearby tissues. By utilising drugs that specifically target proteins and genes instrumental for the growth and survival of cancerous cells, targeted therapy can inhibit cancer cell proliferation or prompt these cells to self-destruct, thus increasing its demand. To illustrate, the American Cancer Society, a non-profit cancer advocacy organization based in the U.S., reported in January 2024 that the number of cancer cases grew from 1,958,310 in 2023 to 2,001,140, indicating a 2.19% growth. Therefore, the rising incidence of cancer is expected to fuel the growth of the targeted therapy market.

Which Segments in the Targeted Therapy Offer the Most Growth?

The targeted therapymarket covered in this report is segmented –

1) By Type: Small Molecule Medicines; Monoclonal Antibodies

2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies

3) By Application: Breast Cancer; Colorectal Cancer; Leukemia; Lung Cancer; Lymphoma; Renal Cancer; Other Applications

Subsegments:

1) By Small Molecule Medicines: Tyrosine Kinase Inhibitors (TKIs); Proteasome Inhibitors; Phosphatidylinositol 3-Kinase (PI3K) Inhibitors; Other Small Molecule Therapies

2) By Monoclonal Antibodies: Immune Checkpoint Inhibitors; Antibody-Drug Conjugates (ADCs); Cytokine Blockers; Other Monoclonal Antibodies

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=9129&type=smp

What Are the Fastest-Growing Geographies in the #How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theTargeted Therapy Market?# Market?

North America was the largest region in the targeted therapy market in 2024. The regions covered in the targeted therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Current Market Growth and Trends in the Targeted Therapy Industry?

Leading entities in the targeted therapy market are prioritizing the creation of novel technological solutions to solidify their market standing. For instance, Novartis AG, a renowned pharmaceutical corporation headquartered in Switzerland, introduced Pluvicto in March 2022, a product that received approval from the US Food and Drug Administration (FDA). Pluvicto is distinguished as the first FDA-sanctioned targeted radioligand therapy (RLT) intended for suitable patients diagnosed with mCRPC. This innovative therapy fuses a healing radioisotope with a specifically targeted chemical (a radioactive particle). Pluvicto is a form of targeted cancer treatment that pairs a therapeutic radioisotope with a specific targeting chemical. When attached, Pluvicto targets cells in the circulation like prostate cancer cells expressing the PSMA transmembrane protein. Once bonded, energy emissions from the radioisotope damage the target cells and other neighbouring cells, inhibiting their ability to replicate and in some instances, causing cell death.

View the full report here:

https://www.thebusinessresearchcompany.com/report/targeted-therapy-global-market-report

What Are the Key Elements That Define the Targeted Therapy Market?

Targeted therapy refers to a kind of cancer treatment that employs medications or other chemicals to attack particular molecules required for the survival and spread of cancer cells. It uses drugs to target specific genes and proteins that help cancer cells survive and grow.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9129

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model